{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:30:36Z","timestamp":1762522236282,"version":"3.44.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T00:00:00Z","timestamp":1541376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes for Health Research","doi-asserted-by":"crossref","award":["MOP-137090"],"award-info":[{"award-number":["MOP-137090"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.virol.2018.11.004","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T13:31:41Z","timestamp":1542288701000},"page":"21-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Polymorphisms of the cytidine deaminase APOBEC3F have different HIV-1 restriction efficiencies"],"prefix":"10.1016","volume":"527","author":[{"given":"Nazanin","family":"Mohammadzadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyson B.","family":"Follack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin P.","family":"Love","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kris","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Sanche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Chelico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2018.11.004_bib1","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1093\/nar\/gkx066","article-title":"Cytidine deaminase efficiency of the lentiviral viral restriction factor APOBEC3C correlates with dimerization","volume":"45","author":"Adolph","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2018.11.004_bib2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1021\/acsinfecdis.7b00221","article-title":"Biochemical basis of APOBEC3 deoxycytidine deaminase activity on diverse DNA substrates","volume":"4","author":"Adolph","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.virol.2018.11.004_bib3","doi-asserted-by":"crossref","first-page":"10209","DOI":"10.1128\/JVI.00632-10","article-title":"Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif function","volume":"84","author":"Albin","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.11.004_bib4","doi-asserted-by":"crossref","first-page":"40785","DOI":"10.1074\/jbc.M110.173161","article-title":"A single amino acid in human APOBEC3F alters susceptibility to HIV-1 Vif","volume":"285","author":"Albin","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2018.11.004_bib5","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1128\/AAC.00137-15","article-title":"Incomplete APOBEC3G\/F neutralization by HIV-1 vif mutants facilitates the genetic evolution from CCR5 to CXCR4 usage","volume":"59","author":"Alteri","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2018.11.004_bib6","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1128\/JVI.78.20.11070-11076.2004","article-title":"APOBEC3G genetic variants and their influence on the progression to AIDS","volume":"78","author":"An","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.11.004_bib7","doi-asserted-by":"crossref","first-page":"e1005921","DOI":"10.1371\/journal.pgen.1005921","article-title":"Role of APOBEC3F gene variation in HIV-1 disease progression and pneumocystis pneumonia","volume":"12","author":"An","year":"2016","journal-title":"PLoS Genet."},{"key":"10.1016\/j.virol.2018.11.004_bib8","doi-asserted-by":"crossref","first-page":"e1004609","DOI":"10.1371\/journal.ppat.1004609","article-title":"Promiscuous RNA binding ensures effective encapsidation of APOBEC3 proteins by HIV-1","volume":"11","author":"Apolonia","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2018.11.004_bib9","doi-asserted-by":"crossref","first-page":"e1004024","DOI":"10.1371\/journal.ppat.1004024","article-title":"Different mutagenic potential of HIV-1 restriction factors APOBEC3G and APOBEC3F is determined by distinct single-stranded DNA scanning mechanisms","volume":"10","author":"Ara","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2018.11.004_bib10","first-page":"91","article-title":"Mechanism of enhanced HIV restriction by virion coencapsidated cytidine deaminases APOBEC3F and APOBEC3G","author":"Ara","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.11.004_bib11","doi-asserted-by":"crossref","first-page":"14380","DOI":"10.1128\/JVI.02484-14","article-title":"Determinants of efficient degradation of APOBEC3 restriction factors by HIV-1 vif","volume":"88","author":"Baig","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.11.004_bib12","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.str.2013.04.010","article-title":"Crystal structure of the DNA cytosine deaminase APOBEC3F: the catalytically active and HIV-1 vif-binding domain","volume":"21","author":"Bohn","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.virol.2018.11.004_bib13","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.jmb.2011.03.058","article-title":"Multifaceted counter-APOBEC3G mechanisms employed by HIV-1 vif","volume":"410","author":"Britan-Rosich","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.virol.2018.11.004_bib14","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.4156","article-title":"Defective proviruses rapidly accumulate during acute HIV-1 infection","volume":"22","author":"Bruner","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2018.11.004_bib15","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1128\/JVI.00676-12","article-title":"APOBEC3G restricts HIV-1 to a greater extent than APOBEC3F and APOBEC3DE in human primary CD4+ T cells and macrophages","volume":"87","author":"Chaipan","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.11.004_bib16","doi-asserted-by":"crossref","first-page":"20120496","DOI":"10.1098\/rstb.2012.0496","article-title":"Host gene evolution traces the evolutionary history of ancient primate lentiviruses","volume":"368","author":"Compton","year":"2013","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.virol.2018.11.004_bib17","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.cub.2003.10.034","article-title":"The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G","volume":"13","author":"Conticello","year":"2003","journal-title":"Curr. Biol."},{"key":"10.1016\/j.virol.2018.11.004_bib18","doi-asserted-by":"crossref","first-page":"10522","DOI":"10.1128\/JVI.01123-06","article-title":"Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family","volume":"80","author":"Dang","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.11.004_bib19","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1128\/JVI.00243-11","article-title":"Identification of a single amino acid required for APOBEC3 antiretroviral cytidine deaminase activity","volume":"85","author":"Dang","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.11.004_bib20","doi-asserted-by":"crossref","first-page":"e1005646","DOI":"10.1371\/journal.ppat.1005646","article-title":"Minimal contribution of APOBEC3-induced G-to-A hypermutation to HIV-1 recombination and enetic variation","volume":"12","author":"Delviks-Frankenberry","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2018.11.004_bib21","doi-asserted-by":"crossref","first-page":"7848","DOI":"10.1093\/nar\/gkw653","article-title":"APOBEC3 proteins can copackage and comutate HIV-1 genomes","volume":"44","author":"Desimmie","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2018.11.004_bib22","doi-asserted-by":"crossref","first-page":"11361","DOI":"10.1128\/JVI.05046-11","article-title":"The breadth of antiviral activity of Apobec3DE in chimpanzees has been driven by positive selection","volume":"85","author":"Duggal","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.11.004_bib23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.virol.2013.05.016","article-title":"Identification and antiviral activity of common polymorphisms in the APOBEC3 locus in human populations","volume":"443","author":"Duggal","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.virol.2018.11.004_bib24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.virol.2013.05.019","article-title":"Elevated hypermutation levels in HIV-1 natural viral suppressors","volume":"443","author":"Eyzaguirre","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.virol.2018.11.004_bib25","doi-asserted-by":"crossref","first-page":"11415","DOI":"10.1074\/jbc.M110.199604","article-title":"Intensity of deoxycytidine deamination of HIV-1 proviral DNA by the retroviral restriction factor APOBEC3G is mediated by the noncatalytic domain","volume":"286","author":"Feng","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2018.11.004_bib26","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1074\/jbc.M112.421875","article-title":"HIV-1 viral infectivity factor (Vif) alters processive single-stranded DNA scanning of the retroviral restriction factor APOBEC3G","volume":"288","author":"Feng","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2018.11.004_bib27","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3389\/fmicb.2014.00450","article-title":"Suppression of APOBEC3-mediated restriction of HIV-1 by Vif","volume":"5","author":"Feng","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virol.2018.11.004_bib28","doi-asserted-by":"crossref","first-page":"27188","DOI":"10.1074\/jbc.M115.666065","article-title":"Natural Polymorphisms and Oligomerization of Human APOBEC3H Contribute to Single-stranded DNA Scanning Ability","volume":"290","author":"Feng","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2018.11.004_bib29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12981-017-0173-8","article-title":"Evasion of adaptive immunity by HIV through the action of host APOBEC3G\/F enzymes","volume":"14","author":"Grant","year":"2017","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.virol.2018.11.004_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature12884","article-title":"Structural basis for hijacking CBF-beta and CUL5 E3 ligase complex by HIV-1 Vif","volume":"505","author":"Guo","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.virol.2018.11.004_bib31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.virol.2015.03.012","article-title":"APOBECs and virus restriction","volume":"479\u2013480","author":"Harris","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.virol.2018.11.004_bib32","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S1097-2765(02)00742-6","article-title":"RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators","volume":"10","author":"Harris","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.virol.2018.11.004_bib33","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0092-8674(03)00423-9","article-title":"DNA deamination mediates innate immunity to retroviral infection","volume":"113","author":"Harris","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.virol.2018.11.004_bib34","doi-asserted-by":"crossref","first-page":"40875","DOI":"10.1074\/jbc.R112.416925","article-title":"The restriction factors of human immunodeficiency virus","volume":"287","author":"Harris","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2018.11.004_bib35","doi-asserted-by":"crossref","first-page":"e1004961","DOI":"10.1371\/journal.ppat.1004961","article-title":"single-cell and single-cycle analysis of HIV-1 replication","volume":"11","author":"Holmes","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2018.11.004_bib36","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1074\/jbc.M607298200","article-title":"APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G","volume":"282","author":"Holmes","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2018.11.004_bib37","doi-asserted-by":"crossref","first-page":"11220","DOI":"10.1128\/JVI.05238-11","article-title":"Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1","volume":"85","author":"Hultquist","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.11.004_bib38","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature10693","article-title":"Vif hijacks CBF-beta to degrade APOBEC3G and promote HIV-1 infection","volume":"481","author":"Jager","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.virol.2018.11.004_bib39","doi-asserted-by":"crossref","first-page":"7973","DOI":"10.1128\/JVI.75.17.7973-7986.2001","article-title":"Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells","volume":"75","author":"Janini","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.11.004_bib40","doi-asserted-by":"crossref","first-page":"e1000367","DOI":"10.1371\/journal.ppat.1000367","article-title":"Likely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistance","volume":"5","author":"Jern","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2018.11.004_bib41","doi-asserted-by":"crossref","first-page":"14943","DOI":"10.1073\/pnas.261419998","article-title":"The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis","volume":"98","author":"Jiang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2018.11.004_bib42","doi-asserted-by":"crossref","first-page":"11398","DOI":"10.1128\/JVI.77.21.11398-11407.2003","article-title":"The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity","volume":"77","author":"Kao","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.11.004_bib43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-4690-1-27","article-title":"Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells","volume":"1","author":"Kao","year":"2004","journal-title":"Retrovirology"},{"key":"10.1016\/j.virol.2018.11.004_bib44","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1128\/JVI.79.3.1975-1980.2005","article-title":"G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo","volume":"79","author":"Kieffer","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.11.004_bib45","doi-asserted-by":"crossref","first-page":"e1004281","DOI":"10.1371\/journal.ppat.1004281","article-title":"Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection","volume":"10","author":"Kim","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2018.11.004_bib46","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nsmb.2378","article-title":"The APOBEC3C crystal structure and the interface for HIV-1 Vif binding","volume":"19","author":"Kitamura","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.virol.2018.11.004_bib47","doi-asserted-by":"crossref","first-page":"8172","DOI":"10.1128\/JVI.01115-08","article-title":"Human immunodeficiency virus (HIV) type 1 proviral hypermutation correlates with CD4 count in HIV-infected women from Kenya","volume":"82","author":"Land","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.11.004_bib48","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1093\/nar\/gki343","article-title":"Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F\/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities","volume":"33","author":"Langlois","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2018.11.004_bib49","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cub.2004.06.050","article-title":"APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo","volume":"14","author":"Liddament","year":"2004","journal-title":"Curr. Biol."},{"key":"10.1016\/j.virol.2018.11.004_bib50","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1089\/aid.2013.0241","article-title":"In vivo HIV-1 hypermutation and viral loads among antiretroviral-naive Brazilian patients","volume":"30","author":"de Lima-Stein","year":"2014","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.virol.2018.11.004_bib51","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature01709","article-title":"Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts","volume":"424","author":"Mangeat","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.virol.2018.11.004_bib52","doi-asserted-by":"crossref","first-page":"14481","DOI":"10.1074\/jbc.C400060200","article-title":"A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action","volume":"279","author":"Mangeat","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2018.11.004_bib53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0092-8674(03)00515-4","article-title":"Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif","volume":"114","author":"Mariani","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.virol.2018.11.004_bib54","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/nm946","article-title":"HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation","volume":"9","author":"Marin","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2018.11.004_bib55","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.tim.2011.03.006","article-title":"Two-stepping through time: mammals and viruses","volume":"19","author":"Meyerson","year":"2011","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.virol.2018.11.004_bib56","doi-asserted-by":"crossref","first-page":"11067","DOI":"10.1128\/JVI.01249-10","article-title":"Stably expressed APOBEC3F has negligible antiviral activity","volume":"84","author":"Miyagi","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.11.004_bib57","doi-asserted-by":"crossref","first-page":"e93428","DOI":"10.1371\/journal.pone.0093428","article-title":"Positioning of APOBEC3G\/F mutational hotspots in the human immunodeficiency virus genome favors reduced recognition by CD8+ T cells","volume":"9","author":"Monajemi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2018.11.004_bib58","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1073\/pnas.0710190105","article-title":"Cytidine deamination induced HIV-1 drug resistance","volume":"105","author":"Mulder","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2018.11.004_bib59","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1128\/JVI.02630-09","article-title":"Moderate influence of human APOBEC3F on HIV-1 replication in primary lymphocytes","volume":"84","author":"Mulder","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.11.004_bib60","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1128\/JVI.02369-15","article-title":"Structural Insights into HIV-1 Vif-APOBEC3F Interaction","volume":"90","author":"Nakashima","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.11.004_bib61","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.272.5259.263","article-title":"In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector","volume":"272","author":"Naldini","year":"1996","journal-title":"Science"},{"year":"2008","series-title":"Lehninger Principles of Biochemistry","author":"Nelson","key":"10.1016\/j.virol.2018.11.004_bib62"},{"key":"10.1016\/j.virol.2018.11.004_bib63","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.chom.2008.07.005","article-title":"Antiretroelement activity of APOBEC3H was lost twice in recent human evolution","volume":"4","author":"OhAinle","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virol.2018.11.004_bib64","doi-asserted-by":"crossref","first-page":"7961","DOI":"10.1128\/JVI.00754-10","article-title":"The localization of APOBEC3H variants in HIV-1 virions determines their antiviral activity","volume":"84","author":"Ooms","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.11.004_bib65","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.chom.2013.09.006","article-title":"HIV-1 vif adaptation to human APOBEC3H haplotypes","volume":"14","author":"Ooms","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virol.2018.11.004_bib66","doi-asserted-by":"crossref","first-page":"9259","DOI":"10.1128\/JVI.00888-06","article-title":"Population level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation","volume":"80","author":"Pace","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.11.004_bib67","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1073\/pnas.87.16.6019","article-title":"Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations","volume":"87","author":"Pathak","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2018.11.004_bib68","doi-asserted-by":"crossref","first-page":"7805","DOI":"10.1128\/JVI.00280-09","article-title":"Analysis of the percentage of human immunodeficiency virus type 1 sequences that are hypermutated and markers of disease progression in a longitudinal cohort, including one individual with a partially defective vif","volume":"83","author":"Piantadosi","year":"2009","journal-title":"J. Virol."},{"issue":"494\u2013506","key":"10.1016\/j.virol.2018.11.004_bib69","doi-asserted-by":"crossref","first-page":"e494","DOI":"10.1016\/j.chom.2017.03.008","article-title":"Defective HIV-1 proviruses are expressed and can be recognized by Cytotoxic T Lymphocytes, which shape the proviral landscape","volume":"21","author":"Pollack","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virol.2018.11.004_bib70","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1097\/QAD.0000000000001113","article-title":"Functional characterization of Vif proteins from HIV-1 infected patients with different APOBEC3G haplotypes","volume":"30","author":"Reddy","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.virol.2018.11.004_bib71","doi-asserted-by":"crossref","first-page":"e1002800","DOI":"10.1371\/journal.ppat.1002800","article-title":"Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n","volume":"8","author":"Refsland","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2018.11.004_bib72","doi-asserted-by":"crossref","first-page":"e1004761","DOI":"10.1371\/journal.pgen.1004761","article-title":"Natural polymorphisms in human APOBEC3H and HIV-1 vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivity","volume":"10","author":"Refsland","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.virol.2018.11.004_bib73","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.celrep.2015.10.067","article-title":"The binding interface between human APOBEC3F and HIV-1 Vif elucidated by genetic and computational approaches","volume":"13","author":"Richards","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.virol.2018.11.004_bib74","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/bioinformatics\/16.4.400","article-title":"Detecting hypermutations in viral sequences with an emphasis on G --> A hypermutation","volume":"16","author":"Rose","year":"2000","journal-title":"Bioinformatics"},{"key":"10.1016\/j.virol.2018.11.004_bib75","doi-asserted-by":"crossref","first-page":"e1004453","DOI":"10.1371\/journal.ppat.1004453","article-title":"APOBEC3D and APOBEC3F potently promote HIV-1 diversification and evolution in humanized mouse model","volume":"10","author":"Sato","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2018.11.004_bib76","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1073\/pnas.0307132101","article-title":"A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif)","volume":"101","author":"Schrofelbauer","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2018.11.004_bib77","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nature00939","article-title":"Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein","volume":"418","author":"Sheehy","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.virol.2018.11.004_bib78","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/nm945","article-title":"The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif","volume":"9","author":"Sheehy","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2018.11.004_bib79","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high-quality protein multiple sequence alignments using clustal omega","volume":"7","author":"Sievers","year":"2011","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.virol.2018.11.004_bib80","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1371\/journal.ppat.0010006","article-title":"Natural variation in Vif: differential impact on APOBEC3G\/3F and a potential role in HIV-1 diversification","volume":"1","author":"Simon","year":"2005","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2018.11.004_bib81","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1038\/ncomms3593","article-title":"Structural determinants of HIV-1 Vif susceptibility and DNA binding in APOBEC3F","volume":"4","author":"Siu","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2018.11.004_bib82","doi-asserted-by":"crossref","first-page":"12599","DOI":"10.1128\/JVI.01437-10","article-title":"Identification of specific determinants of human APOBEC3F, APOBEC3C, and APOBEC3DE and African green monkey APOBEC3F that interact with HIV-1 Vif","volume":"84","author":"Smith","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.11.004_bib83","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/QAI.0000000000000689","article-title":"Impact of APOBEC mutations on CD8+ T cell recognition of HIV epitopes varies depending on the restricting HLA","volume":"70","author":"Squires","year":"2015","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.virol.2018.11.004_bib84","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1097-2765(03)00353-8","article-title":"HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability","volume":"12","author":"Stopak","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.virol.2018.11.004_bib85","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1128\/jvi.65.4.1779-1788.1991","article-title":"Selection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes","volume":"65","author":"Vartanian","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.11.004_bib86","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1073\/pnas.91.8.3092","article-title":"G-->A hypermutation of the human immunodeficiency virus type 1 genome: evidence for dCTP pool imbalance during reverse transcription","volume":"91","author":"Vartanian","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2018.11.004_bib87","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1099\/0022-1317-83-4-801","article-title":"Sustained G-->A hypermutation during reverse transcription of an entire human immunodeficiency virus type 1 strain Vau group O genome","volume":"83","author":"Vartanian","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2018.11.004_bib88","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1128\/JVI.02049-10","article-title":"Analysis of human APOBEC3H haplotypes and anti-human immunodeficiency virus type 1 activity","volume":"85","author":"Wang","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.11.004_bib89","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1038\/sj.emboj.7600246","article-title":"A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins","volume":"23","author":"Wiegand","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.virol.2018.11.004_bib90","doi-asserted-by":"crossref","first-page":"e1005865","DOI":"10.1371\/journal.ppat.1005865","article-title":"A single nucleotide polymorphism in human APOBEC3C enhances restriction of lentiviruses","volume":"12","author":"Wittkopp","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2018.11.004_bib91","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1073\/pnas.0400830101","article-title":"A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion","volume":"101","author":"Xu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2018.11.004_bib92","doi-asserted-by":"crossref","first-page":"e1005833","DOI":"10.1371\/journal.ppat.1005833","article-title":"The RNA binding specificity of human APOBEC3 proteins resembles That of HIV-1 nucleocapsid","volume":"12","author":"York","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2018.11.004_bib93","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nsmb758","article-title":"Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome","volume":"11","author":"Yu","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.virol.2018.11.004_bib94","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1126\/science.1089591","article-title":"Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex","volume":"302","author":"Yu","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.virol.2018.11.004_bib95","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.virol.2005.12.035","article-title":"Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates","volume":"349","author":"Zennou","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.virol.2018.11.004_bib96","doi-asserted-by":"crossref","first-page":"D754","DOI":"10.1093\/nar\/gkx1098","article-title":"Ensembl 2018","volume":"46","author":"Zerbino","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2018.11.004_bib97","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature01707","article-title":"The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA","volume":"424","author":"Zhang","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.virol.2018.11.004_bib98","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature10718","article-title":"T-cell differentiation factor CBF-beta regulates HIV-1 Vif-mediated evasion of host restriction","volume":"481","author":"Zhang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.virol.2018.11.004_bib99","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.1128\/JVI.78.11.6073-6076.2004","article-title":"Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication","volume":"78","author":"Zheng","year":"2004","journal-title":"J. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682218303453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682218303453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:46:26Z","timestamp":1758588386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682218303453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":99,"alternative-id":["S0042682218303453"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2018.11.004","relation":{},"ISSN":["0042-6822"],"issn-type":[{"type":"print","value":"0042-6822"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymorphisms of the cytidine deaminase APOBEC3F have different HIV-1 restriction efficiencies","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2018.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}